Cognitive Impairment trials recruiting in Massachusetts

All Cognitive Impairment trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
  NCT06191965 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 35 Years · Sex: All (male and female) · Massachusetts: Belmont
• Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
  NCT05245903 · Phase: Not specified · Ages: 18 Years to 89 Years · Sex: All (male and female) · Massachusetts: Belmont
• Study of ALTO-101 in Patients With Schizophrenia
  NCT06502964 · Phase: Phase 2 · Ages: 21 Years to 55 Years · Sex: All (male and female) · Massachusetts: Belmont